Cardiol Therapeutics (CRDL) Assets: 2021
Historic Assets for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $70.1 million.
- Cardiol Therapeutics' Assets rose 107.93% to $52.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $52.4 million, marking a year-over-year increase of 107.93%. This contributed to the annual value of $70.1 million for FY2021, which is N/A change from last year.
- As of FY2021, Cardiol Therapeutics' Assets stood at $70.1 million.
- Cardiol Therapeutics' Assets' 5-year high stood at $70.1 million during FY2021, with a 5-year trough of $70.1 million in FY2021.
- Its 1-year average for Assets is $70.1 million, with a median of $70.1 million in 2021.